Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
NIH/National Institute of Child Health and Human Development
Common treatment to delay labor decreases pre-term infants' risk for cerebral palsy
September 11th, 2008
Preterm infants born to mothers receiving intravenous magnesium sulfate—a common treatment to delay labor—are less likely to develop cerebral palsy than are preterm infants whose mothers do not receive it, report researchers in a large National Institutes of Health research network. The study results appear in the August 28, 2008 New England Journal of Medicine. "A third of all cases of cerebral palsy are associated with preterm birth," said NIH Director Elias A. Zerhouni, M.D. "This study shows a significant reduction in cerebral palsy among preterm infants whose mothers were given magnesium sulfate." The researchers theorized...
Source: Women's Health Weekly (2008-09-11)
|
